Literature DB >> 19225273

Hypopituitarism in the elderly: two case-reports with heterogeneous presentation.

Luca Foppiani1, Antonio Ruelle, Paolo Quilici, Patrizia Del Monte.   

Abstract

Hypopituitarism (HYPO) is an under-investigated disease in older patients. Symptoms, which may be life-threatening, are aspecific and often attributed to aging and/or related morbidities. We describe here the cases of two elderly patients who were ultimately diagnosed as having HYPO, the clinical presentations and etiologies of which were different. In the first patient, an invasive non-secreting pituitary macroadenoma causing HYPO was detected on brain morphological evaluation for head trauma secondary to falling. Glucocorticoid replacement therapy was started. Thyroid function evaluation showed hyperthyroidism (due to a known toxic multinodular goiter), which was already on treatment with methimazole; ultimately, after withdrawal of the antithyroid drug, secondary hypothyroidism occurred. The patient underwent non-radical pituitary surgery. Cognitive function, gait impairment and falling, which had previously been attributed only to aging, improved markedly after cortisone acetate and L-thyroxine replacement therapy. The second patient was hospitalized one month after the onset of hypotension, edema and pain in the legs, and progressive psychomotor impairment, which ultimately resulted in an intermittent soporous state. She was diagnosed as having global anterior HYPO secondary to empty sella, which caused severe multifaceted clinical and biochemical abnormalities (hyponatremia, pancytopenia, rhabdomyolysis). After treatment with i.v. fluids and hydrocortisone, the patient's clinical condition and biochemical alterations improved, and normalized over time with oral cortisone acetate and Lthyroxine combination therapy. Several protean symptoms that impair the quality of life of elderly patients are usually ascribed to aging. Such symptoms should be investigated with regard to possible HYPO, treatment of which can result in significant clinical benefit.

Entities:  

Mesh:

Year:  2009        PMID: 19225273     DOI: 10.1007/bf03324902

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  5 in total

1.  Practice of symptomatic treatment in the era of evidence-based medicine: report of 2 cases of diagnosis of Sheehan's syndrome delayed till eighth decade.

Authors:  Abdul Majid Wani; Waleed Mohd Hussain; Mousa Ali Al Mejally; Abdulhakeem Amroon Banjar; Khaled Shawkat Ali; Amer Mohd Khoujah; Sadeya Hanif Raja; Mazen G Bafaraj; Wail Al Miamini; Mubeena Akhtar
Journal:  BMJ Case Rep       Date:  2010-05-06

2.  Severe hyponatremia caused by secondary adrenal insufficiency in a patient with giant pituitary prolactinoma.

Authors:  Akimitsu Kobayashi; Yasushi Otsuka; Takeo Yoshizawa; Masuomi Tomita; Hideo Asada; Jun Ikeda; Masato Saito; Katsuyoshi Tojo; Satoru Kuriyama; Tastuo Hosoya
Journal:  CEN Case Rep       Date:  2013-02-09

Review 3.  Hormones and the bone marrow: panhypopituitarism and pancytopenia in a man with a pituitary adenoma.

Authors:  Dianna Lang; Jennifer S Mead; David B Sykes
Journal:  J Gen Intern Med       Date:  2015-05       Impact factor: 5.128

4.  Hematological response of pancytopenia to glucocorticoids in patients with Sheehan's syndrome.

Authors:  Bashir Ahmad Laway; Shahnaz Ahmad Mir; Javid Rasool Bhat; Mohd Iqbal Lone; Jeelani Samoon; Abdul Hamid Zargar
Journal:  Pituitary       Date:  2012-06       Impact factor: 4.107

Review 5.  Isolated Adrenocorticotropic Hormone Deficiency Presenting with Severe Hyponatremia and Rhabdomyolysis: A Case Report and Literature Review.

Authors:  Takeshi Komatsu; Nobumasa Ohara; Naoko Hirota; Yuichiro Yoneoka; Takashi Tani; Keishi Terajima; Tetsutaro Ozawa; Hirohito Sone
Journal:  Am J Case Rep       Date:  2019-12-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.